Finance entity
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Evolent Health, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.2.
Last mentioned: Feb 24, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
earnings is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Evolent Health, the most common co-covered peer. At 5, the average consequence score sits below the same-window beat average of 6.2. Each story carries 2 original sources on average, compared with 2.4 for the broader beat in this window. Standard BioTools appears in 1 tracked Finance story from February 24, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 85 Finance stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Standard BioTools. Shared-story counts are live from our verified record — not editorial picks.
Standard BioTools and Evolent Health released their Q4 and full-year 2025 financial results, marking a critical inflection point for both the life sciences tools and value-based care sectors. The reports highlight a focus on operational efficiency and the integration of large-scale acquisitions as both companies navigate a complex macroeconomic environment.
Standard BioTools is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
